To the management of NUPATHE, since you won't answer any e-mails, phone calls or conference question,
CAN YOU PLEASE HAVE A PRESS RELEASE FOR THE LTS APPROVAL FROM THE FDA ON cGMP ON ZECUITY?
Thank-you, a concerned stock holder wanting to increase shareholder value.
Sent to people at Nupathe. Everyone else should something like it as well, the cap part.
Sentiment: Strong Buy